1.
Koyama S, Yu H, Dalgarno DC, Shin TB, Zydowsky LD, Schreiber SL. 1H and 15N assignments and secondary structure of the PI3K SH3 domain. FEBS Lett. 1993;324(1):93-8.
1.
Yu H, Rosen MK, Schreiber SL. 1H and 15N assignments and secondary structure of the Src SH3 domain. FEBS Lett. 1993;324(1):87-92.
1.
Koyama S, Yu H, Dalgarno DC, Shin TB, Zydowsky LD, Schreiber SL. Structure of the PI3K SH3 domain and analysis of the SH3 family. Cell. 1993;72(6):945-52.
1.
Yu H, Rosen MK, Shin TB, Seidel-Dugan C, Brugge JS, Schreiber SL. Solution structure of the SH3 domain of Src and identification of its ligand-binding site. Science. 1992;258(5088):1665-8.
1.
Ferrer M, Kapoor TM, Strassmaier T, et al. Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements. Nat Struct Biol. 1999;6(10):953-60. doi:10.1038/13324.
1.
Choi J, Chen J, Schreiber SL, Clardy J. Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science. 1996;273(5272):239-42.
1.
Ke H, Mayrose D, Belshaw PJ, et al. Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4-dimethylthreonine cyclosporin A. Structure. 1994;2(1):33-44.
1.
Van Duyne GD, Standaert RF, Karplus PA, Schreiber SL, Clardy J. Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J Mol Biol. 1993;229(1):105-24. doi:10.1006/jmbi.1993.1012.
1.
Jakobsche CE, Choudhary A, Miller SJ, Raines RT. n --> pi* Interaction and n)(pi Pauli repulsion are antagonistic for protein stability. J Am Chem Soc. 2010;132(19):6651-3. doi:10.1021/ja100931y.
1.
Farutin V, Robison K, Lightcap E, et al. Edge-count probabilities for the identification of local protein communities and their organization. Proteins. 2006;62(3):800-18. doi:10.1002/prot.20799.